Capital Fund Management (CFM)’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.95M | Buy |
126,279
+86,333
| +216% | +$1.33M | 0.01% | 627 |
|
|
2025
Q1 | $594K | Buy |
+39,946
| New | +$594K | ﹤0.01% | 709 |
|
|
2024
Q2 | – | Sell |
-69,026
| Closed | -$959K | – | 1049 |
|
|
2024
Q1 | $959K | Sell |
69,026
-25,920
| -27% | -$360K | ﹤0.01% | 585 |
|
|
2023
Q4 | $1.35M | Buy |
+94,946
| New | +$1.35M | ﹤0.01% | 568 |
|
|
2022
Q3 | – | Sell |
-66,141
| Closed | -$929K | – | 898 |
|
|
2022
Q2 | $929K | Buy |
66,141
+37,557
| +131% | +$527K | 0.01% | 472 |
|
|
2022
Q1 | $409K | Buy |
28,584
+4,481
| +19% | +$64.2K | ﹤0.01% | 558 |
|
|
2021
Q4 | $329K | Buy |
+24,103
| New | +$329K | ﹤0.01% | 546 |
|
|
2020
Q1 | – | Sell |
-90,513
| Closed | -$1.79M | – | 1196 |
|
|
2019
Q4 | $1.79M | Sell |
90,513
-309
| -0.3% | -$6.1K | 0.01% | 394 |
|
|
2019
Q3 | $1.56M | Sell |
90,822
-2,755
| -3% | -$47.4K | 0.01% | 375 |
|
|
2019
Q2 | $1.66M | Sell |
93,577
-3,129
| -3% | -$55.4K | 0.02% | 371 |
|
|
2019
Q1 | $1.97M | Buy |
+96,706
| New | +$1.97M | 0.02% | 394 |
|